Followers | 1 |
Posts | 70 |
Boards Moderated | 0 |
Alias Born | 02/27/2019 |
Saturday, March 14, 2020 7:28:48 AM
The point I was trying to make is this: your stated cost is $0.75, hempspeculator's is $0.50, Xpedian's is $1.00. All three of you had talked to Johnson.
OTOH, the early EXDI investors bought at $0.20. The question was, how many of your (and otherss') certificates were passed from these early investors. That was the whole point I was trying to make.
Regarding the SEC filings, it was obvious in April that the company was waffling on its retail strategy, when they backed out of the HempHealthy deal. That's the genesis of their retail failures that were highlighted here recently by Cane5 and biznesman. However you and hempspeculator did not realize that, even though you were talking to Johnson. That was the issue. I am not certain why both you (now) and hempspeculator (in January) got so passionately offended when this is being brought up.
The stock dropped ~33% on the Monday after the Friday the HempHealthy fail was disclosed in an 8-K. So some people noticed, but you and hempspeculator did not know about it for months after that, even though you were talking to Johnson regularly. You may not be retired (I apologize for calling you retired), but certainly you were being naive.
Also, there are a million other red flags around Johnson and the communication practices of EXDI that he was in charge of. Really!
Recent PLSH News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 03:28:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 07:24:23 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/08/2023 08:04:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 05:07:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 01:15:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/20/2023 04:21:21 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/15/2023 03:28:18 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 03:19:11 PM
- Panacea Life Sciences Holdings, Inc. Chief Scientific Officer, Dr. James Baumgartner, is Featured on The Stock Day Podcast • InvestorsHub NewsWire • 07/18/2023 04:41:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2023 01:00:13 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM